MARKET

NBY

NBY

NOVABAY PHARMA
AMEX

Real-time Quotes | Nasdaq Last Sale

0.9202
+0.0505
+5.81%
After Hours: 0.9105 -0.0097 -1.05% 19:29 03/05 EST
OPEN
0.8800
PREV CLOSE
0.8697
HIGH
0.9282
LOW
0.7851
VOLUME
1.52M
TURNOVER
--
52 WEEK HIGH
1.940
52 WEEK LOW
0.2400
MARKET CAP
38.45M
P/E (TTM)
-2.2422
1D
5D
1M
3M
1Y
5Y
U.S. Infectious Diseases Official Fauci Says it's Possible Americans Will Still be Wearing Masks in 2022
-CNN
CNN · 02/21 14:29
Alpha Pro Tech, NovaBay Pharmaceuticals Shares Quiet; U.S. Democrats Plan To Increase PPP Funding In Stimulus $813.7B
-Reuters -Reuters 
Reuters -Reuters  · 02/09 15:26
BRIEF-NovaBay Expect Avenova To Be On Shelves Of Up To 3,000 CVS Pharmacy Stores Across U.S. By Feb End
reuters.com · 02/08 11:54
NovaBay CEO Issues Letter to Stockholders
NovaBay Pharmaceuticals (NYSE:NBY) issued the following Letter to Stockholders: To My Fellow Stockholders: NovaBay Pharmaceuticals enters 2021 focused on growing sales of our high-quality, differentiated consumer
Benzinga · 02/08 11:50
Fauci Says CDC May Recommend Wearing Two Masks To Fight Virus
-Reuters 
Reuters  · 02/02 14:59
Alpha Pro Tech Shares See Volume; President Biden Says 'Masks, Not Vaccines' Are Best Defense Against COVID-19
-Reuters -Reuters 
Reuters -Reuters  · 01/26 22:05
Biden to Order Mask Wearing on Federal Property
-Bloomberg
Bloomberg · 01/20 10:05
MARA, GME, FRSX and ZOM among midday movers
Gainers: Live Ventures (LIVE) +87%.GameStop (GME) +63%.Exela Technologies (XELA) +51%.AMMO (POWW) +41%.Castor Maritime (CTRM) +35%.Acorda Therapeutics (ACOR) +32%.Root (ROOT) +32%.Ondas Holdings (ONDS) +30%.NuCana (NCNA) +26%.Foresight Autonomous (FRSX) +26%.Losers: Asia Pacific Wire & Cable (APWC) -27%.Zomedica (ZOM) -26%.Forward Pharma
Seekingalpha · 01/13 17:45
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NBY. Analyze the recent business situations of NOVABAY PHARMA through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NBY stock price target is 2.625 with a high estimate of 3.500 and a low estimate of 1.750.
EPS
Institutional Holdings
Institutions: 20
Institutional Holdings: 647.60K
% Owned: 1.55%
Shares Outstanding: 41.78M
TypeInstitutionsShares
Increased
3
383.59K
New
7
174.48K
Decreased
6
97.70K
Sold Out
2
12.42K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.94%
Pharmaceuticals & Medical Research
+1.63%
Key Executives
Non-Executive Chairman/Independent Director
Paul Freiman
President/Chief Executive Officer/Director/IR Contact Officer
Justin Hall
Chief Financial Officer/Treasurer
Andrew Jones
Controller
Wang Xu
Director
Xinzhou Li
Director
Mijia Wu
Independent Director
Swan Sit
Independent Director
Yenyou Zheng
No Data
About NBY
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox. Its Avenova with Neutrox removes debris from the skin on the eyelids and lashes without burning or stinging. It develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. Its Aganocide compounds, led by auriclosene (NVC-422), are synthetic molecules with activity against bacteria, viruses and fungi. The Company's dermatology product includes CelleRx, a cleansing solution for post laser resurfacing, chemical peels and other cosmetic surgery procedures. Its wound care business includes the business of NeutroPhase product.

Webull offers kinds of NovaBay Pharmaceuticals, Inc. stock information, including AMEX:NBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NBY stock methods without spending real money on the virtual paper trading platform.